These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12504768)

  • 1. Valproic acid and lamotrigine treatment during pregnancy. The risk of chromosomal abnormality.
    Ozkinay F; Cogulu O; Gunduz C; Yilmaz D; Kultursay N
    Mutat Res; 2003 Jan; 534(1-2):197-9. PubMed ID: 12504768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy.
    Holmes LB; Baldwin EJ; Smith CR; Habecker E; Glassman L; Wong SL; Wyszynski DF
    Neurology; 2008 May; 70(22 Pt 2):2152-8. PubMed ID: 18448870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes.
    Jentink J; Boersma C; de Jong-van den Berg LT; Postma MJ
    J Med Econ; 2012; 15(5):862-8. PubMed ID: 22494266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal epilepsy and birth defects: a case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC).
    Bertollini R; Mastroiacovo P; Segni G
    Eur J Epidemiol; 1985 Mar; 1(1):67-72. PubMed ID: 3939491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity of lamotrigine.
    Shor S; Koren G; Nulman I
    Can Fam Physician; 2007 Jun; 53(6):1007-9. PubMed ID: 17872777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
    Hockey A; Bower C; Goldblatt J; Knowles S
    Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345
    [No Abstract]   [Full Text] [Related]  

  • 8. Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies.
    Dolk H; Wang H; Loane M; Morris J; Garne E; Addor MC; Arriola L; Bakker M; Barisic I; Doray B; Gatt M; Kallen K; Khoshnood B; Klungsoyr K; Lahesmaa-Korpinen AM; Latos-Bielenska A; Mejnartowicz JP; Nelen V; Neville A; O'Mahony M; Pierini A; Rißmann A; Tucker D; Wellesley D; Wiesel A; de Jong-van den Berg LT
    Neurology; 2016 May; 86(18):1716-25. PubMed ID: 27053714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gollop-Wolfgang Complex in a baby born to an epileptic mother treated with valproic acid during pregnancy].
    Mercadal Orfila G; Blasco Mascaró I
    Farm Hosp; 2010; 34(3):149-51. PubMed ID: 20471572
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital malformations associated with maternal use of valproic acid.
    Huot C; Gauthier M; Lebel M; Larbrisseau A
    Can J Neurol Sci; 1987 Aug; 14(3):290-3. PubMed ID: 3117346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Valproic acid responsible for low IQ].
    Homberg V
    MMW Fortschr Med; 2015 Sep; 157(15):42. PubMed ID: 26349723
    [No Abstract]   [Full Text] [Related]  

  • 12. Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.
    Pariente G; Leibson T; Shulman T; Adams-Webber T; Barzilay E; Nulman I
    CNS Drugs; 2017 Jun; 31(6):439-450. PubMed ID: 28434134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The first case of a child born with fetal valproic acid syndrome in Hungary].
    Robinek F; Czeizel E
    Orv Hetil; 1989 Jan; 130(5):267. PubMed ID: 2492655
    [No Abstract]   [Full Text] [Related]  

  • 14. Fetal valproate syndrome.
    Clayton-Smith J; Donnai D
    J Med Genet; 1995 Sep; 32(9):724-7. PubMed ID: 8544193
    [No Abstract]   [Full Text] [Related]  

  • 15. Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
    Tomson T; Klein P
    Neurology; 2015 Jan; 84(4):339-40. PubMed ID: 25540318
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate and pregnancy: think again.
    Kalayjian LA
    Neurology; 2015 Jan; 84(4):e25-6. PubMed ID: 25628438
    [No Abstract]   [Full Text] [Related]  

  • 17. Short- and long-term complications of in utero exposure to lamotrigine.
    Cohen-Israel M; Berger I; Martonovich EY; Klinger G; Stahl B; Linder N
    Br J Clin Pharmacol; 2018 Jan; 84(1):189-194. PubMed ID: 29044597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Septo-optic dysplasia as a manifestation of valproic acid embryopathy.
    McMahon CL; Braddock SR
    Teratology; 2001 Aug; 64(2):83-6. PubMed ID: 11460259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
    Mawer G; Bromley R; Baker GA; Meador KJ; Clayton-Smith J
    Neurology; 2015 Oct; 85(15):1354. PubMed ID: 26459942
    [No Abstract]   [Full Text] [Related]  

  • 20. Teratogenicity of sodium valproate.
    Alsdorf R; Wyszynski DF
    Expert Opin Drug Saf; 2005 Mar; 4(2):345-53. PubMed ID: 15794725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.